Abstract
The glycocalyx is a biologically active barrier that covers the luminal side of the vascular endothelium and it is comprised of proteoglycans [core proteins with glycosaminoglycans (GAG) side chains], glycoproteins, and plasma proteins. Evidence shows that the disruption in the structure and function of the endothelial glycocalyx exacerbates vascular inflammation and atherosclerosis. The GAG components of the glycocalyx undergo remodeling in the setting of diabetes and these alterations in endothelial GAGs negatively impact the vascular function. Hence, the preservation and restoration of GAGs in altered vasculature may be a novel strategy to ameliorate vascular complications in diabetes and metabolic syndrome. Human studies support the beneficial vascular effects of flavonoids which are widely found in fruits and vegetables. Flavonoids are extensively metabolized by the intestinal microbiota and digestive enzymes in humans, suggesting that their biological activities may be mediated by their circulating metabolites. Studies indicate that counteracting the damage to GAGs using dietary compounds improve vascular complications. In this article, we describe the methods to analyze the effect of diet-derived metabolites such as metabolites of flavonoids on endothelial inflammation and cell surface glycosaminoglycans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kolsen-Petersen JA (2015) The endothelial glycocalyx: the great luminal barrier. Acta Anaesthesiol Scand 59(2):137–139
Kolarova H et al (2014) Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediators Inflamm 2014:694312
Becker BF et al (2015) Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol 80(3):389–402
Broekhuizen LN et al (2010) Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 53(12):2646–2655
Gowd V, Gurukar A, Chilkunda ND (2016) Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation. World J Diabetes 7(4):67–73
Wasty F, Alavi MZ, Moore S (1993) Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 36(4):316–322
Mooij HL et al (2014) Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function. J Am Heart Assoc 3(6):e001274
Babu P et al (2011) Hydrogen/deuterium exchange-LC-MS approach to characterize the action of heparan sulfate C5-epimerase. Anal Bioanal Chem 401(1):237–244
Han J, Hiebert LM (2014) Reprint of “Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin”. Vasc Pharmacol 59(3–4):112–118
Hiebert LM, Han J, Mandal AK (2014) Glycosaminoglycans, hyperglycemia, and disease. Antioxid Redox Signal 21(7):1032–1043
Wang F et al (2009) Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid. Am J Physiol Heart Circ Physiol 296(4):H1108–H1116
Wang F et al (2012) Fatty acid-induced nuclear translocation of heparanase uncouples glucose metabolism in endothelial cells. Arterioscler Thromb Vasc Biol 32(2):406–414
Vikramadithyan RK et al (2004) Atherosclerosis in perlecan heterozygous mice. J Lipid Res 45(10):1806–1812
Tran-Lundmark K et al (2008) Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circ Res 103(1):43–52
Rodriguez-Mateos A et al (2013) Intake and time dependence of blueberry flavonoid-induced improvements in vascular function: a randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am J Clin Nutr 98(5):1179–1191
Cassidy A et al (2013) High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 127(2):188–196
Basu A et al (2010) Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 140(9):1582–1587
Rodriguez-Mateos A et al (2014) Impact of processing on the bioavailability and vascular effects of blueberry (poly)phenols. Mol Nutr Food Res 58(10):1952–1961
Johnson SA et al (2015) Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet 115(3):369–377
Del Bo C et al (2017) A serving of blueberry (V. corymbosum) acutely improves peripheral arterial dysfunction in young smokers and non-smokers: two randomized, controlled, crossover pilot studies. Food Funct 8(11):4108–4117
Kalea AZ et al (2006) Wild blueberry (Vaccinium angustifolium) consumption affects the composition and structure of glycosaminoglycans in Sprague-Dawley rat aorta. J Nutr Biochem 17(2):109–116
Kristo AS et al (2012) Wild blueberry (V. angustifolium)-enriched diets alter aortic glycosaminoglycan profile in the spontaneously hypertensive rat. J Nutr Biochem 23(8):961–965
de Ferrars RM et al (2014) The pharmacokinetics of anthocyanins and their metabolites in humans. Br J Pharmacol 171(13):3268–3282
de Ferrars RM et al (2014) Phenolic metabolites of anthocyanins following a dietary intervention study in post-menopausal women. Mol Nutr Food Res 58(3):490–502
Bharat D et al (2018) Blueberry metabolites attenuate lipotoxicity-induced endothelial dysfunction. Mol Nutr Food Res 62(2):1700601
Cutler B et al (2018) Blueberry metabolites restore cell surface glycosaminoglycans and attenuate endothelial inflammation in diabetic human aortic endothelial cells. Int J Cardiol 261:155–158
Zeng Y, Tarbell JM (2014) The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS One 9(1):e86249
Koo A, Dewey CF Jr, Garcia-Cardena G (2013) Hemodynamic shear stress characteristic of atherosclerosis-resistant regions promotes glycocalyx formation in cultured endothelial cells. Am J Physiol Cell Physiol 304(2):C137–C146
Acknowledgments
This work was supported by the National Institute of Health (R01AT010247) and National Institute of Foods and Agriculture (2019-67017-29253) grants (to P.V.A.B.); Undergraduate Research Opportunities Program award (to B.R.C.); and NHLBI sponsored Programs of Excellence in Glycosciences Grant, HL107152 (to K.B.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Cutler, B.R., Chua, J.S., Balagurunathan, K., Anandh Babu, P.V. (2022). Methods to Analyze the Effect of Diet-Derived Metabolites on Endothelial Inflammation and Cell Surface Glycosaminoglycans. In: Balagurunathan, K., Nakato, H., Desai, U., Saijoh, Y. (eds) Glycosaminoglycans. Methods in Molecular Biology, vol 2303. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1398-6_37
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1398-6_37
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1397-9
Online ISBN: 978-1-0716-1398-6
eBook Packages: Springer Protocols